-
Loading metrics
Open Access
Peer-reviewed
Research Article
Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents
-
Leslie W. Tari ,
* E-mail: ltari@triusrx.com (LWT); jfinn@triusrx.com (JF)
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Xiaoming Li,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Michael Trzoss,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Daniel C. Bensen,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Zhiyong Chen,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Thanh Lam,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Junhu Zhang,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Suk Joong Lee,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Grayson Hough,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Doug Phillipson,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Suzanne Akers-Rodriguez,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Mark L. Cunningham,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Bryan P. Kwan,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Kirk J. Nelson,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Amanda Castellano,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Jeff B. Locke,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Vickie Brown-Driver,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Timothy M. Murphy,
Current address: UNT Health Science Center, Fort Worth, Texas, United States of America
Affiliation ViviSource Laboratories, Waltham
⨯ -
Voon S. Ong,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ -
Chris M. Pillar,
Affiliation Micromyx LLC, Kalamazoo, Michigan, United States of America
⨯ -
Dean L. Shinabarger,
Affiliation Micromyx LLC, Kalamazoo, Michigan, United States of America
⨯ -
Jay Nix,
Affiliation Advanced Light Source, Beamline 4.2.2, Berkeley, California, United States of America
⨯ -
Felice C. Lightstone,
Affiliation Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Livermore, California, United States of America
⨯ -
Sergio E. Wong,
Affiliation Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Livermore, California, United States of America
⨯ -
Toan B. Nguyen,
Affiliation Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Livermore, California, United States of America
⨯ -
Karen J. Shaw,
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ - [ ... ],
-
John Finn
* E-mail: ltari@triusrx.com (LWT); jfinn@triusrx.com (JF)
Affiliation Trius Therapeutics, San Diego, California, United States of America
⨯ - [ view all ]
- [ view less ]
Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents
- Leslie W. Tari,
- Xiaoming Li,
- Michael Trzoss,
- Daniel C. Bensen,
- Zhiyong Chen,
- Thanh Lam,
- Junhu Zhang,
- Suk Joong Lee,
- Grayson Hough,
- Doug Phillipson
- Published: December 26, 2013
- https://doi.org/10.1371/journal.pone.0084409